Indutrade has some 160 subsidaries and more than 3,800 employees in  23 countries on four continents. In 2011 net sales amounted to SEK 7,994 million and EBITA amounted to SEK    917 million. The EBITA margin was 11.5%. Net profit amounted to SEK   540 million and earnings per share were SEK 13.50.

Indutrade acquired Rubin Medical AB, Sweden, with annual sales of approximately SEK 100 million, a supplier of medical technology products with a focus on diabetes therapy in Scandinavia.

Are you thinking about selling your business and yet see it expand and develop? Maybe Indutrade is the alternative for you. Contact us for an unprejudiced discussion. More information at the link below.

Listen to CEO Johnny Alvarsson commenting on the Q1 Report 2012.